Facio to discover FSHD clinical outcome measures based on real-world data

Tuesday, March 19, 2019

Facio Therapies announced that it entered an agreement with the Centre for Human Drug Research (CHDR; Leiden, the Netherlands) on a study aimed at discovering FSHD clinical outcome measures based on real-world patient data obtained with the use of digital technologies. This exploratory study, which is co-financed by Facio and CHDR and will be conducted with the co-operation of the group of leading FSHD clinician, Prof. Baziel van Engelen (Nijmegen, the Netherlands), represents the very first effort in the FSHD field to evaluate the utility of real-world data for monitoring disease progression and response to treatment. Read more

Find the right employees! You can easily upload your vacancies at the My Park section. Please contact Carla van der Laan.